Tuesday, December 9 1:00 PM – 2:00 PM EST With the Centers for Medicare & Medicaid Services’ (CMS) announcement of the GENErating cost Reductions for U.S. Medicaid (GENEROUS) Model, life science companies, states and other stakeholders are seeking to understand how the Most Favored Nation (MFN) pricing model may impact them and Medicaid patients seeking […]
Tuesday, December 9
The GENEROUS Model: What it Means for Life Science Companies, States and Patients
